glutamine supports pancreatic cancer growth kras-regulated metabolic pathway 
cancer cells metabolic dependencies distinguish normal counterparts among dependencies increased use amino acid glutamine fuel anabolic processes indeed spectrum glutamine-dependent tumours mechanisms whereby glutamine supports cancer metabolism remain areas active investigation report identification non-canonical pathway glutamine use human pancreatic ductal adenocarcinoma pdac cells required tumour growth whereas cells use glutamate dehydrogenase glud1 convert glutamine-derived glutamate alpha-ketoglutarate mitochondria fuel tricarboxylic acid cycle pdac relies distinct pathway glutamine-derived aspartate transported cytoplasm can converted oxaloacetate aspartate transaminase got1 subsequently oxaloacetate converted malate pyruvate ostensibly increasing nadph/nadp+ ratio can potentially maintain cellular redox state importantly pdac cells strongly dependent series reactions glutamine deprivation genetic inhibition enzyme pathway leads increase reactive oxygen species reduction reduced glutathione moreover knockdown component enzyme series reactions also results pronounced suppression pdac growth vitro vivo furthermore establish reprogramming glutamine metabolism mediated oncogenic kras signature genetic alteration pdac transcriptional upregulation repression key metabolic enzymes pathway essentiality pathway pdac fact dispensable normal cells may provide novel therapeutic approaches treat refractory tumours 
